What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
His primary scientific interests are in Lung cancer, Pathology, Internal medicine, Cancer research and Metastasis.
Pan-Chyr Yang has included themes like Cancer, Adenocarcinoma, Respiratory disease, Carcinoma and Macrophage in his Lung cancer study.
Pan-Chyr Yang has researched Pathology in several fields, including Inflammation and Gene expression.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Surgery and Oncology.
His work deals with themes such as Cell culture, microRNA, Immunology and Epidermal growth factor receptor, which intersect with Cancer research.
His studies deal with areas such as Cell growth, Cancer cell, Carcinogenesis, Microarray and Tumor progression as well as Metastasis.
His most cited work include:
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma (3017 citations)
- MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib (1330 citations)
- A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer (754 citations)
What are the main themes of his work throughout his whole career to date?
Pan-Chyr Yang mainly investigates Internal medicine, Lung cancer, Cancer research, Cancer and Oncology.
As part of one scientific family, Pan-Chyr Yang deals mainly with the area of Internal medicine, narrowing it down to issues related to the Surgery, and often Respiratory disease.
His research in Lung cancer intersects with topics in Carcinoma, Epidermal growth factor receptor and Adenocarcinoma.
His study looks at the relationship between Cancer research and topics such as Metastasis, which overlap with Slug.
Pan-Chyr Yang does research in Cancer, focusing on Cancer stem cell specifically.
Pan-Chyr Yang studies Pathology, namely Immunohistochemistry.
He most often published in these fields:
- Internal medicine (32.97%)
- Lung cancer (36.15%)
- Cancer research (32.77%)
What were the highlights of his more recent work (between 2015-2021)?
- Cancer research (32.77%)
- Lung cancer (36.15%)
- Internal medicine (32.97%)
In recent papers he was focusing on the following fields of study:
Pan-Chyr Yang focuses on Cancer research, Lung cancer, Internal medicine, Oncology and Adenocarcinoma.
His Cancer research research integrates issues from Cell, Cancer cell, Apoptosis, Metastasis and Immunotherapy.
His Metastasis course of study focuses on Slug and Epithelial–mesenchymal transition, Hypoxia, Death-associated protein 6 and HDAC1.
His Lung cancer research includes themes of Cancer, Epidermal growth factor receptor and Tyrosine-kinase inhibitor.
His Oncology research is multidisciplinary, incorporating elements of Reverse transcription polymerase chain reaction, PI3K/AKT/mTOR pathway, Disease and Chemotherapy.
His Adenocarcinoma study combines topics in areas such as Carcinogenesis, Pathology, Lung, Gene silencing and Single-nucleotide polymorphism.
Between 2015 and 2021, his most popular works were:
- The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients (136 citations)
- Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma (79 citations)
- Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations. (78 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
His primary areas of study are Cancer research, Internal medicine, Lung cancer, Oncology and Adenocarcinoma.
His Cancer research study incorporates themes from Epidermal growth factor receptor, Apoptosis, Immunology, Metastasis and Immunotherapy.
His Metastasis research incorporates themes from Slug and Cancer cell.
His work carried out in the field of Internal medicine brings together such families of science as Mutation, Reverse transcription polymerase chain reaction and Psychological intervention.
The Gefitinib research Pan-Chyr Yang does as part of his general Lung cancer study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science.
His Adenocarcinoma research incorporates elements of Disease, Pathology, Lung, Tumor progression and Single-nucleotide polymorphism.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
